33.1 C
Delhi
Sunday, September 27, 2020

Minimal impact of Covid-19 on Indian pharma industry: ICRA

- Advertisement -

Outbreak in China hits Indian pharmaceutical unitsNew Delhi, Aug 7 (IANS) The domestic pharma industry is expected to grow at a 4-6 per cent in FY-2021 owing to Covid impact, though FY 2020-2023, CAGR is expected to be in the range of 8-11 per cent on the back of healthy demand from the domestic market given increasing spend on healthcare along with improving access, rating agency ICRA has said.

In its analysis of the pharma industry in India, the rating agency said that along with demand growth in India, moderation in pricing pressure for US market, new launches and market share gains for existing products and consolidation benefits will drive growth for the industry over the medium term.

Several Indian pharma companies (Aurobindo, Dr. Reddy, Glenmark) have acquired US ANDA (abbreviated new drug application) portfolios which will aid growth going forward. The growth in FY-2021 is expected to be supported by 1.88 per cent WPI linked price hike for domestic NLEM (National List of Essential Medicines) portfolio.

The prospect for current year comes on the backdrop of the Indian pharmaceutical industry’s stable growth of eight per cent during FY-2020 led by rebound in domestic growth in Q2 FY-2020 to 14.2 per cent (Q1 FY-20 at 4.8 per cent) supported by seasonal factors and stable growth in chronic therapies.

Based on the trends, ICRA Vice President and Co-Head Gaurav Jain said, “The global demand scenario is largely expected to remain stable for Indian pharmaceutical industry owing to inelastic nature of prescription drugs though some impact on volume growth will be felt owing to lockdown (lesser OPDs/elective surgeries) and lower economic growth. The impact of lower demand will be felt more in less developed countries which are additionally negatively impacted owing to low crude oil prices.”

As per ICRA research, post onset of Covid-19, manufacturing activity has gradually started in China with shipments/air cargo arriving in India for APIs, Intermediates and KSMs (Key Starting Materials). This has led to production continuation for Indian players though the capacity utilization across plants is yet to reach pre-Covid-19 levels.

The lower capacity utilization is largely contributed by restricted movement of personnel and availability of non-critical raw material (e.g. packaging material) during the lockdown period in India. Indian players hold 2-4 months of inventory (raw material & finished goods) and similar levels in distribution channel (finished goods) which will largely suffice demand in the near term till situation normalizes.

The outbreak of the Coronavirus in China and the consequent lockout in parts of China had earlier resulted in a shutdown of production units in China. The domestic pharmaceutical industry is highly dependent on imports, with more than 60 per cent of its active pharmaceutical ingredients (API) requirement being imported, and in some, specific APIs like cephalosporins, azithromycin and penicillin, the dependence is as high as 80-90 per cent. Of the total imports of APIs and intermediates into India, China accounts for 65-70 per cent.

The recent introduction of Rs 10,000 crore bulk drugs park and production linked incentives for API manufacturers by the Government of India will lead to reduced dependence for the domestic formulators on imports from China and augurs well in the long run to manage supply disruptions, the agency said.

The incentive scheme covers 53 APIs which are critical from import dependence on China with few API/KSM being entirely imported.

As for the growth and profitability, the same would however be constrained by regulatory interventions such as price controls, compulsory genericisation for domestic market. For the US market, faster generic approvals and continued regulatory overhang with respect to manufacturing quality deficiencies highlighted during USFDA audits remains key concern.

The pace of ANDA approvals has more than doubled over the FY 2014-2019 period leading to higher competitive intensity. The pace of official action post USFDA audit has also increased during the FY-2019 period with 16 warning letters compared to seven in FY-2018.

The margins have remained flattish in FY-2020 at 20.3 per cent for ICRA sample of 14 leading companies led by cost cutting measures including R&D optimisation efforts by Indian Players. Though margins remain healthy, pricing pressures for the US base generics business (albeit moderating); lack of limited competition products and manufacturing quality issues will continue to put margin pressure. Higher share of domestic business and operational efficiencies will provide overall cushion to margins.

Unlike in the past, when several Indian pharma companies ramped up their R&D spend, targeting pipeline of specialty drugs, niche molecules and complex therapies, this time around companies are optimising their R&D spend owing to above mentioned factors. Also, with competitive pressures expected to sustain in the near to medium term, companies are exiting product development of easy to manufacture, simple generics with multiple players and focusing on complex generics and specialty products.

According to ICRA, Indian companies are unlikely to significantly modify current spend on R&D development which will support their long-term growth prospects. With R&D optimization efforts underway to counter US pricing pressure, the aggregate R&D spend is expected to be maintain at current levels of 6.5-7.5 per cent compared to earlier 8-9 per cent for sample companies. This will be despite requirements arising from expanding presence in complex therapy segment such as injectables, inhalers, dermatology, controlled-release substances and even biosimilars.

Source: IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

Former Defence Minister Jaswant Singh passes away

New Delhi, Sep 27 (IANS) Former Defence Minister Jaswant Singh passed away early Sunday, said an official statement from the R&R Hospital here. He...

BJP’s oldest ally Akali Dal quits NDA over ‘black laws’

Chandigarh, Sep 26 (IANS) The highest decision making body of the Shiromani Akali Dal (SAD) core committee at its emergency meeting held here on...

Gill stars as clinical KKR thrash SRH by 7 wkts

Abu Dhabi, Sep 27 (IANS/GloFans) Opener Shubhman Gill's unbeaten 70-run knock along with Eoin Morgan's 42 not out guided Kolkata Knight Riders (KKR) to...

RBI to retain lending rates, accommodative stance, say experts

By Rohit Vaid (IANS) Persistently high inflation fanned in part due to supply side disruptions along with seasonal factors will deter the Reserve Bank...

Amazon Echo devices to automatically delete your recordings

New Delhi, Sep 27 (IANS) After launching new Alexa and Echo devices, Amazon has introduced additional privacy controls and easier ways for the customers....

Uma Bharti, Ram Madhav among key leaders dropped from BJP’s office-bearers list

New Delhi, Sep 26 (PTI) With several BJP leaders making way for fresh faces in the new list of the party''s national office-bearers announced...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Will Govt have 80,000 crores available over the next one year?, saks Adar Poonawalla

New Delhi, Sep 26 (IANS) Rs 80,000 crore will be the cost of vaccinating everyone in India with the Covid-19 vaccine whenever it is...

Will Govt have 80,000 crores available over the next one year?, saks Adar Poonawalla

New Delhi, Sep 26 (IANS) Rs 80,000 crore will be the cost of vaccinating everyone in India with the Covid-19 vaccine whenever it is...

Centre puts price caps on medical oxygen after shortage reports

New Delhi, Sep 26 (IANS) In order to deal with shortage of medical oxygen and the resultant increase in prices in the country, the...

Huge infrastructure build-up helped India recovery rate: Dr Harsh Vardhan

New Delhi, September 26 (ANI): Union Health Minister Dr Harsh Vardhan on Friday said that huge infrastructure build-up to counter the COVID -19 situation...

Aarogya Setu loses sheen as downloads drop

New Delhi/Noida, Sep 25 (IANS) Prashant Kumar who lives in Noida sector 143 often goes to a nearby mall-cum-office complex with his family for...

PM Modi asks states to focus on micro-containment zones

New Delhi, Sep 23 (PTI) Prime Minister Narendra Modi on Wednesday asked states to reassess if lockdowns of one or two days are effective...

Trending News In India

NCB seizes phones of Deepika, Rakul, Simone, Karishma in drugs case

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB), which quizzed Bollywood actors Rakul Preet Singh, Deepika Padukone, her former manager Karishma Prakash, and...

Self-sufficient in defence linked to ‘self-respect’, ‘sovereignty’ of country: Rajnath

New Delhi, Sep 27 (PTI) Defence Minister Rajnath Singh on Saturday said a country that depends on imports for its military equipment can never...

BJP’s oldest ally Akali Dal quits NDA over ‘black laws’

Chandigarh, Sep 26 (IANS) The highest decision making body of the Shiromani Akali Dal (SAD) core committee at its emergency meeting held here on...

NCB seizes phones of Deepika, Rakul, Simone, Karishma in drugs case

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB), which quizzed Bollywood actors Rakul Preet Singh, Deepika Padukone, her former manager Karishma Prakash, and...

Gill stars as clinical KKR thrash SRH by 7 wkts

Abu Dhabi, Sep 27 (IANS/GloFans) Opener Shubhman Gill's unbeaten 70-run knock along with Eoin Morgan's 42 not out guided Kolkata Knight Riders (KKR) to...

RBI to retain lending rates, accommodative stance, say experts

By Rohit Vaid (IANS) Persistently high inflation fanned in part due to supply side disruptions along with seasonal factors will deter the Reserve Bank...

Trending Showbiz

NCB seizes phones of Deepika, Rakul, Simone, Karishma in drugs case

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB), which quizzed Bollywood actors Rakul Preet Singh, Deepika Padukone, her former manager Karishma Prakash, and...

NCB quizzes Deepika, Sara, Shraddha in drug case related to SSR death

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB) on Saturday questioned Bollywood divas Deepika Padukone, Sara Ali Khan, Shraddha Kapoor for several hours...

‘CBI delay in converting abetment to suicide to murder frustrating’

Mumbai, Sep 25 (IANS) Vikas Singh, family lawyer of late actor Sushant Singh Rajput, on Friday stated that the delay being by Central Bureau...

NCB questions Rakul, Deepika’s ex-manager, Dharma Productions honcho

Mumbai, Sep 25 (IANS) The Narcotics Control Bureau (NCB) on Friday is questioning Bollywood actor Rakul Preet Singh, Dharma Productions executive producer Kshitij Ravi...

Famed singer S.P. Balasubrahmanyam succumbs to Covid-19

Chennai, Sep 25 (IANS) Famed playback singer and Padma awardee S.P. Balasubrahmanyam, or popularly SPB or Balu in the movie world and who has...

WhatsApp clarifies after probe agencies retrieve chats

New Delhi, Sep 25 (IANS) The Narcotics Control Bureau (NCB) cloned the mobile phones of Rhea Chakraborty and others, which gave them access to the WhatsApp chats...

Trending Sports

Gill stars as clinical KKR thrash SRH by 7 wkts

Abu Dhabi, Sep 27 (IANS/GloFans) Opener Shubhman Gill's unbeaten 70-run knock along with Eoin Morgan's 42 not out guided Kolkata Knight Riders (KKR) to...

I am surprised Sanju Samson is not representing India in all formats, says Warne

Dubai, Sep 27 (PTI) Spin legend Shane Warne on Saturday expressed his "surprise" that wicketkeeper-batsman Sanju Samson is not playing for India across formats.Samson...

Shaw and Rabada propel Delhi to big win over Dhoni’s CSK

Dubai, Sep 26 (IANS/GloFans) In yet another dismal show, three-time IPL champions Chennai Super Kings (CSK) suffered a 44-run defeat against a charged-up Delhi Capitals (DC) here on...

KL Rahul’s record-breaking ton blows RCB away

Dubai, Sep 25 (IANS/GloFans) Captain K.L. Rahul on Thursday shattered a few IPL records with a blistering 69-ball 132 not out -- the highest individual...

Sat on bench for hours after losing in 1992 Oly quarters, reveals Paes

New Delhi, Sep 25 (IANS) Eighteen-time Grand Slam champion Leander Paes made history in 1996 when he became the first Indian tennis player to...

Ex-Australian cricketer Dean Jones dies of cardiac arrest in Mumbai

New Delhi, Sep 24 (IANS) Former Australian cricketer Dean Jones passed away in Mumbai on Thursday after suffering a cardiac arrest. The 59-year-old was...

Latest Trending News In India

Former Defence Minister Jaswant Singh passes away

New Delhi, Sep 27 (IANS) Former Defence Minister Jaswant Singh passed away early Sunday, said an official statement from the R&R Hospital here. He...

Self-sufficient in defence linked to ‘self-respect’, ‘sovereignty’ of country: Rajnath

New Delhi, Sep 27 (PTI) Defence Minister Rajnath Singh on Saturday said a country that depends on imports for its military equipment can never...

BJP’s oldest ally Akali Dal quits NDA over ‘black laws’

Chandigarh, Sep 26 (IANS) The highest decision making body of the Shiromani Akali Dal (SAD) core committee at its emergency meeting held here on...

NCB seizes phones of Deepika, Rakul, Simone, Karishma in drugs case

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB), which quizzed Bollywood actors Rakul Preet Singh, Deepika Padukone, her former manager Karishma Prakash, and...

Gill stars as clinical KKR thrash SRH by 7 wkts

Abu Dhabi, Sep 27 (IANS/GloFans) Opener Shubhman Gill's unbeaten 70-run knock along with Eoin Morgan's 42 not out guided Kolkata Knight Riders (KKR) to...